mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.009 |
mRNA |
SMER-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.097 |
0.01 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.01 |
mRNA |
BRD-K70511574 |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.01 |
mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.073 |
0.01 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.01 |
mRNA |
Oxaliplatin |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.01 |
mRNA |
JQ-1:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.01 |
mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.01 |
mRNA |
BRD-K66453893 |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.01 |